School of Medicine
Showing 41-49 of 49 Results
Professor of Genetics
Current Research and Scholarly InterestsWe apply diverse genomic approaches to understand how genetic variation affects health and disease by: 1) functional and mechanistic analyses of gene regulation, 2) studies of meiotic recombination and inheritance, 3) analyses of genetic and environmental interactions, and 4) characterization of diseases in human cells and model organisms. We integrate wet lab and computational genomic, transcriptomic, proteomic and metabolic approaches, and develop technologies to enable personalized medicine.
Jordan R. Stern, MD
Clinical Associate Professor, Surgery - Vascular Surgery
BioDr. Stern is a board-certified, fellowship-trained specialist in vascular surgery in the Stanford Vascular and Endovascular Care program. He is a Clinical Associate Professor in the Department of Surgery at Stanford University School of Medicine.
Dr. Stern’s clinical and academic interests focus on the treatment of aortic disease. He is a leader in the development of novel treatment strategies for aortic pathology and specializes in minimally invasive, endovascular repair of complex aneurysms and aortic dissection.
For each patient, he develops a personalized treatment plan. The goal is the best possible vascular health and quality of life for every individual in his care.
Patients praise Dr. Stern’s knowledge and attention to detail. They also appreciate his kindness and compassion, his approachability, and the effort he makes to thoroughly answer all questions from patients and their families.
In addition to providing expert patient care, he is the principal investigator on several clinical trials. He is also involved in many additional research endeavors, examining contemporary practice patterns and outcomes from endovascular and open surgical procedures.
He has published the results of his research in numerous journal articles. They have appeared in the Journal of Vascular Surgery, Journal of the American College of Surgery, and many other peer-reviewed journals. The majority of his publications have focused on aortic disease.
He is an editorial board member of the journal Annals of Vascular Surgery and previously was an assistant editor of the Journal of Endovascular Therapy. He also has co-authored chapters in textbooks such as Novel and Evolving Aortic Endovascular Devices and the Atlas of Vascular and Endovascular Techniques.
Dr. Stern has presented his research discoveries to his peers at international, national, and regional meetings. He is a fellow of the Society for Vascular Surgery. He is a member of the Vascular and Endovascular Surgery Society (VESS), where he also serves as inaugural chair of the VESS Research Consortium as well as on the Program Committee. He is a fellow of the American College of Surgeons and a member of the Society for Clinical Vascular Surgery and Western Vascular Society.
Simon H. Stertzer, MD, FACC,FAHA,FACP
Professor of Medicine (Cardiovascular) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsCoronary Angioplasty; Intramyocardial Stem cell delivery
Frank E. Stockdale
Maureen Lyles D'Ambrogio Professor in the School of Medicine, Emeritus
Current Research and Scholarly InterestsLaboratory and clinical research in breast cancer ; Normal and abornal differentiation and growth
Ga Young Suh
Adjunct Professor, Surgery - Vascular Surgery
BioAfter completion of MS/PhD from Mechanical Engineering, I've been with Division of Vascular Surgery at Stanford since 2011. I am motivated to apply Engineering-based techniques to patient anatomy or medical device. Also, I am actively teaching and training undergrad students, medical school students and trainees.
Katrin J Svensson
Assistant Professor of Pathology
Current Research and Scholarly InterestsMolecular metabolism
Cell biology and function
James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances.
Ali Bin Syed
Clinical Assistant Professor, Radiology - Pediatric Radiology
BioDr. Syed is a member of the divisions of Pediatric Radiology and Body MRI. His clinical interests include MR imaging of pediatric and adult hepatobiliary disorders, inflammatory bowel disease, gynecologic pathology, and congenital heart disease. He is also an active researcher, collaborating with fellow engineers and scientists at Stanford to translate technical innovations in MRI into improved patient care. His recent work focuses on rapid, motion-robust MRI in children and adults.
Daniel Sze, MD, PhD
Professor of Radiology (Interventional Radiology)
Current Research and Scholarly InterestsTransarterial administration of chemotherapeutics, radioactive microspheres, and biologics for the treatment of unresectable tumors; management of portal hypertension and complications of cirrhosis (TIPS); treatment of complications of organ transplantation; Venous and pulmonary arterial thrombolysis and reconstruction; Stent and Stent-graft treatment of peripheral vascular diseases, aneurysms, aortic dissections